NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1080225004

Registered date:06/01/2020

CAR-T Long Term Follow Up Study

Basic Information

Recruitment status recruiting
Health condition(s) or Problem(s) studiedAny patients have received a Novartis or Penn CAR-T therapy
Date of first enrollment15/01/2020
Target sample size14
Countries of recruitmentJapan,North America,Europe,Oceania
Study typeOther
Intervention(s)Previously treated CAR-T patients

Outcome(s)

Primary OutcomeSafety Delayed AEs that are suspected to be related to previous CAR T-cell therapy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderBoth
Include criteriaAll patients who have received a CAR-T therapy and completed or discontinued early from a Novartis sponsored treatment protocol that utilized CAR-T cells or from any CAR-T trial sponsored by the University of Pennsylvania with which Novartis has a contractual agreement to co-develop the CAR technology. Patients who have provided informed consent for the long term follow up study prior to their study participation.
Exclude criteriaThere are no specific exclusion criteria for this study.

Related Information

Contact

Public contact
Name Takamitsu Hirano
Address Toranomon Hills Mori Tower 23-1, Toranomon 1-chome Minato-ku, Tokyo 105-6333, Japan
Telephone +81-120-003-293
E-mail rinshoshiken.toroku2@novartis.com
Affiliation Novartis Pharma. K.K.
Scientific contact
Name Takamitsu Hirano
Address Toranomon Hills Mori Tower 23-1, Toranomon 1-chome Minato-ku, Tokyo 105-6333, Japan
Telephone +81-120-003-293
E-mail rinshoshiken.toroku2@novartis.com
Affiliation Novartis Pharma. K.K.